Close

content

Sun Pharma launches first branded ophthalmic product, BromSiteâ„¢, in USA

Sun Pharma announced the launch of BromSiteâ„¢ (bromfenac ophthalmic solution) 0.075% in the US market.A nonsteroidal anti-inflammatory drug indicated for the treatment of postoperative...

PMMI Releases Newly Revised ANSI/PMMI B155.1-2016 Standard

PMMI, The Association for Packaging and Processing Technologies, is pleased to announce the approval of its ANSI/PMMI B155.1-2016 Safety Requirements for Packaging and Processing...

Arrow Generiques to acquire select assets in France from Teva

Arrow Generiques SAS, the French subsidiary of Aurobindo Pharma Ltd announced the signing of an agreement to acquire select commercial products in France from...

GSK Starts Phase III Programme with Daprodustat for Anemia Associated with Chronic Kidney Disease

GlaxoSmithKline plc announced the start of a phase III development programme investigating daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a treatment...

NINLAROTM Receives Conditional Approval from the European Commission to Treat Multiple Myeloma

Takeda Pharmaceutical Company Limited announced that the EC has granted conditional marketing authorization for NINLAROTM (ixazomib)capsules, indicated in combination with lenalidomide and dexamethasone for...

Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial

Eli Lilly and Company announced that solanezumab did not meet the primary endpoint in the EXPEDITION3 clinical trial, a phase 3 study of solanezumab...

Sun Pharma to acquire Biosintez in Russia 

Sun Pharma announced the execution of definitive agreements by its wholly owned subsidiary, for the acquisition of 85.1% of JSC Biosintez, a Russian pharmaceutical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read